Summary of Key Points
On July 13th, Huashan Hospital affiliated with Fudan University completed the world's first commercial implantation of a brain-computer interface (NEO system) that has been approved for market use. The patient was a person with quadriplegia caused by cervical spinal cord injury. This technology captures brain electrical signals to identify movement intentions and uses pneumatic gloves to help patients regain their ability to grasp objects. The NEO system has already been included in Shanghai's "Hu Hui Bao" medical insurance program. This marks a significant step from laboratory research to clinical application, offering hope to the 3.7 million spinal cord injury patients in China. However, there are still challenges to overcome, such as patient selection, accessibility of payment options, and replication of treatment outcomes.
Detailed Explanation
How Does This Brain-Computer Interface Help Patients Regain Grasping Ability?
The problem for patients with spinal cord injuries is that their brains want to move, but the signals are blocked by the damaged spinal cord, preventing their limbs from responding. The NEO system works by creating a new pathway between the brain and the hands:
- Step 1: Collecting Brain Electrical Signals: Electrodes the size of a coin are implanted between the skull and the dura mater (without piercing the brain) to capture electrical signals related to hand movements. These signals are clearer than those collected from the scalp and safer than direct implantation into the brain.
- Step 2: Identifying Movement Intentions: Algorithms analyze the signals to determine whether the patient intends to grasp or relax.
- Step 3: Controlling Glove Movements: The system converts these intentions into commands to control the pneumatic gloves, enabling the patient to perform grasping actions.
Clinical trials have shown that 32 patients had a 100% response rate in grasping tasks with the device assistance three months after surgery, and 62.5% of the patients also improved their ability to grasp objects without the device (for example, they could pick up a cup on their own). It's important to note that this does not cure paralysis; it only helps patients regain some self-care abilities and does not enable them to walk again.
Who Among the 3.7 Million Patients Can Actually Benefit from This Technology?
The total number of spinal cord injury patients is 3.7 million, but not everyone will be eligible:
- Location of Injury: The NEO system is currently only designed for quadriplegia caused by cervical spinal cord injuries (inability to move below the neck and loss of grasping ability in the fingers).
- Physical Conditions: Patients must be between 18 and 65 years old, have had a stable condition for at least six months (no further deterioration), have a functioning motor cortex in the brain, and have normal cognitive abilities to cooperate with training.
- Persistence in Training: The device requires daily use for six hours or more for a month. Since each patient's brain electrical signals are unique, the algorithm needs to learn these signals, and patients must learn how to send clear commands.
Therefore, only a small portion of the 3.7 million patients—those with cervical spinal cord injuries who meet the criteria and are willing to persist in training—can actually benefit from this technology. The 3.7 million figure represents the potential demand, not the number of patients that can be served immediately.
Are Payment and Accessibility the Biggest Barriers?
Even if the technology is excellent, it will be of little use if patients cannot afford it or if hospitals are unable to provide the necessary services:
- Payment: The NEO system is included in Shanghai's "Hu Hui Bao" insurance, but the specific costs for the device, surgery, and rehabilitation services, as well as the coverage ratio, are not yet clear. These factors will affect patients' willingness to try the technology.
- Accessibility: Hospitals need specialized personnel (neurosurgeons for electrode implantation, rehabilitation teams for training) and multidisciplinary collaboration (neurology, rehabilitation, engineering). Since only Huashan Hospital has performed the first surgery, other hospitals need time to train staff and establish the necessary procedures.
Additionally, the company behind the technology, Borui Kang, primarily earns revenue from non-invasive products (such as electroencephalogram machines). The profitability of invasive brain-computer interfaces is still being tested.
What Other Applications Could This Technology Offer in the Future?
Grasping ability is just the beginning; the potential of brain-computer interfaces is vast:
- Epilepsy Treatment: A sister product, NEO-ONE ANS, is currently in clinical trials and can monitor abnormal brain activity to automatically stimulate the brain to stop seizures in cases where medication is ineffective.
- Lower Limbs and Language: In the future, this technology could help patients walk (by controlling exoskeletons), recover language functions (by decoding brain signals), and perform fine motor tasks (such as writing with a pen).
Huashan Hospital has also mentioned that as the technology matures, it could be applied to other conditions beyond cervical spinal cord injuries. However, all of this requires further research, clinical trials, and regulatory approval.
Conclusion
This first surgical implantation marks a milestone in the transition of brain-computer interfaces from science fiction to practical applications. While it is an important breakthrough, it is not a miracle cure. Patients must go through rigorous selection processes, hospitals need to establish comprehensive support systems, and companies must address issues related to payment and accessibility. For the 3.7 million spinal cord injury patients, the door to hope has been opened, but there is still a long way to go before this technology becomes widely available and affordable.
(End of translation)